Developmental Delay — Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program
Citation(s)
Achenbach, T M., & Rescorla, L. A. (2001). Manual for the ASEBA Preschool Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families.
Bracken, B A. (2007). Bracken School Readiness Assessment. San Antonio, TX: Psychological Corporation.
Brestan , E V. , Eyberg , S. M. , Algina , J. , Bennett Johnson , S. , & Boggs , S. R. ( 2003 ). How annoying is it? Defining parental tolerance for child misbehavior. Child and Family Behavior Therapy, 25, 1-15.
Brestan, E V., Jacobs, J. R., Rayfield, A. D., & Eyberg, S. M. (2000). A consumer satisfaction measure for parent-child treatments and its relation to measures of child behavior change. Behavior Therapy, 30, 17-30.
Cain, J (2005). The Way I Feel. Chicago, IL: Parenting Press.
Cain, J (2009). Asi Me Sientol. Chicago, IL: Parenting Press.
Donenberg G, Baker BL The impact of young children with externalizing behaviors on their families. J Abnorm Child Psychol. 1993 Apr;21(2):179-98.
Eyberg, S M., & Funderburk, B. W. (2011). Parent-Child Interaction Therapy Protocol. Gainesville, FL: PCIT International.
Eyberg, S M., & Pincus, D. (1999). Eyberg Child Behavior Inventory and Sutter-Eyberg Student Behavior Inventory: Professional manual. Odessa, FL: Psychological Assessment Resources.
Eyberg, S M., Nelson, M. M., Ginn, N. C., Bhuiyan, N., & Boggs, S. R. (2013). Dyadic Parent- Child Interaction Coding System (DPICS): Comprehensive manual for research and training. Gainesville, FL: PCIT International.
Goldsmith, H H., Reilly, J (1993). Laboratory Assessment of Temperament Preschool Version. University of Oregon.
Guy, W (1976). ECDEU assessment manual for psychopharmacology. Rockville, MD: US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration.
Hall, L (1983). Social supports, everyday stressors, and maternal mental health (Unpublished doctoral dissertation). University of North Carolina at Chapel Hill.
Kazdin AE, Holland L, Crowley M, Breton S Barriers to Treatment Participation Scale: evaluation and validation in the context of child outpatient treatment. J Child Psychol Psychiatry. 1997 Nov;38(8):1051-62.
Lovibond, S H. & Lovibond, P.F. (1995). Manual for the Depression Anxiety & Stress Scales. (2 Ed.)Sydney: Psychology Foundation.
Nguyen TD, Attkisson CC, Stegner BL Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983;6(3-4):299-313.
Owens JA, Spirito A, McGuinn M The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000 Dec 15;23(8):1043-51.
Pons, J I., Flores-Pabón, L., Matías-Carrelo, L., Rodríguez, M., Rosario-Hernández, E., Rodríguez, J. M., . . . Yang, J. (2008). Confiabilidad de la Escala de Inteligencia Wechsler para Adultos Versión III, Puerto Rico (EIWA-III). Revista Puertorriqueña de Psicología, 19, 112-132.
Turner EA The parental attitudes toward psychological services inventory: adaptation and development of an attitude scale. Community Ment Health J. 2012 Aug;48(4):436-49. doi: 10.1007/s10597-011-9432-7. Epub 2011 Jun 21.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
